These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 7915179)

  • 1. Biopharmaceutical evaluation of salicylazosulfanilic acid as a novel colon-targeted prodrug of 5-aminosalicylic acid.
    Yamaguchi T; Sasaki K; Kurosaki Y; Nakayama T; Kimura T
    J Drug Target; 1994; 2(2):123-31. PubMed ID: 7915179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and in vitro/in vivo evaluation of 5-aminosalicyl-glycine as a colon-specific prodrug of 5-aminosalicylic acid.
    Jung YJ; Lee JS; Kim YM
    J Pharm Sci; 2000 May; 89(5):594-602. PubMed ID: 10756325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and properties of polysaccharide prodrugs of 5-aminosalicylic acid as potential colon-specific delivery systems.
    Zou M; Okamoto H; Cheng G; Hao X; Sun J; Cui F; Danjo K
    Eur J Pharm Biopharm; 2005 Jan; 59(1):155-60. PubMed ID: 15567313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and properties of 5-aminosalicyl-taurine as a colon-specific prodrug of 5-aminosalicylic acid.
    Jung YJ; Kim HH; Kong HS; Kim YM
    Arch Pharm Res; 2003 Apr; 26(4):264-9. PubMed ID: 12735682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis.
    Jung Y; Kim HH; Kim H; Kong H; Choi B; Yang Y; Kim Y
    Eur J Pharm Sci; 2006 May; 28(1-2):26-33. PubMed ID: 16455235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of a colon delivery capsule to 5-aminosalicylic acid and evaluation of the pharmacokinetic profile after oral administration to beagle dogs.
    Takaya T; Sawada K; Suzuki H; Funaoka A; Matsuda K; Takada K
    J Drug Target; 1997; 4(5):271-6. PubMed ID: 9169983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis and prediction of absorption behavior of colon-targeted prodrug in rats by GI-transit-absorption model.
    Yokoe J; Iwasaki N; Haruta S; Kadono K; Ogawara K; Higaki K; Kimura T
    J Control Release; 2003 Jan; 86(2-3):305-13. PubMed ID: 12526826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of 5-aminosalicyl-glycine as a potential colon-specific prodrug of 5-aminosalicylic acid.
    Jung YJ; Lee JS; Kim HH; Kim YM; Han SK
    Arch Pharm Res; 1998 Apr; 21(2):174-8. PubMed ID: 9875427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and properties of N,N'-bis(5-aminosalicyl)-L-cystine as a colon-specific deliverer of 5-aminosalicylic acid and cystine.
    Kim H; Kim D; Choi D; Jeon H; Han J; Jung Y; Kong H; Kim YM
    Drug Deliv; 2008 Jan; 15(1):37-42. PubMed ID: 18197522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colon-specific prodrugs of 5-aminosalicylic acid: synthesis and in vitro/in vivo properties of acidic amino acid derivatives of 5-aminosalicylic acid.
    Jung YJ; Lee JS; Kim YM
    J Pharm Sci; 2001 Nov; 90(11):1767-75. PubMed ID: 11745734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and properties of dextran-5-aminosalicylic acid ester as a potential colon-specific prodrug of 5-aminosalicylic acid.
    Jung YJ; Lee JS; Kim HH; Kim YT; Kim YM
    Arch Pharm Res; 1998 Apr; 21(2):179-86. PubMed ID: 9875428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid.
    Klotz U
    Clin Pharmacokinet; 1985; 10(4):285-302. PubMed ID: 2864155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Aminosalicylic Acid Azo-Linked to Procainamide Acts as an Anticolitic Mutual Prodrug via Additive Inhibition of Nuclear Factor kappaB.
    Kim W; Nam J; Lee S; Jeong S; Jung Y
    Mol Pharm; 2016 Jun; 13(6):2126-35. PubMed ID: 27112518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and preclinical development of a novel prodrug conjugate of mesalamine with eicosapentaenoic acid and caprylic acid for the treatment of inflammatory bowel diseases.
    Kandula M; Sunil Kumar KB; Palanichamy S; Rampal A
    Int Immunopharmacol; 2016 Nov; 40():443-451. PubMed ID: 27716592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N,N'-Bis(5-aminosalicyl)-L-cystine is a potential colon-specific 5-aminosalicylic acid prodrug with dual therapeutic effects in experimental colitis.
    Kim H; Huh J; Jeon H; Choi D; Han J; Kim Y; Jung Y
    J Pharm Sci; 2009 Jan; 98(1):159-68. PubMed ID: 18399548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid for colon-specific drug delivery in inflammatory bowel disease.
    Dhaneshwar SS; Kandpal M; Vadnerkar G; Rathi B; Kadam SS
    Eur J Med Chem; 2007 Jun; 42(6):885-90. PubMed ID: 17258353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A colon-specific prodrug of metoclopramide ameliorates colitis in an experimental rat model.
    Yang Y; Kim W; Kim D; Jeong S; Yoo JW; Jung Y
    Drug Des Devel Ther; 2019; 13():231-242. PubMed ID: 30643389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Aminosalicylic acid containing drugs. Delivery, fate, and possible clinical implications in man.
    Christensen LA
    Dan Med Bull; 2000 Feb; 47(1):20-41. PubMed ID: 10709142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acid derivatives of 5-ASA as novel prodrugs for intestinal drug delivery.
    Clerici C; Gentili G; Boschetti E; Santucci C; Aburbeh AG; Natalini B; Pellicciari R; Morelli A
    Dig Dis Sci; 1994 Dec; 39(12):2601-6. PubMed ID: 7995185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and development of novel azo prodrugs using various permutations and combinations of 5- and 4-aminosalicylic acids for inflammatory bowel disease: a colon-targeted approach.
    Suneela D; Gaurav V; Himanshu R
    Inflamm Allergy Drug Targets; 2013 Oct; 12(5):328-40. PubMed ID: 24001333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.